In addition to hosting clinical trial consortia, academic medical centers are also increasingly engaging with private partners in biomarker discovery
BPC-157 (as PL-14736) was evaluated in early human inflammatory-bowel-disease/ulcerative-colitis trials and reportedly in multiple-sclerosis trials
Prescription GLP-1 vs Compounded Weight Loss Injections: Key Differences Understanding the differences between prescription GLP-1 vs compounded weight loss injections can help patients make informed decisions
Differences in patient populations, trial duration, dose escalation, baseline weight, diabetes status, adherence, and estimand strategy limit direct comparisons
This suggestion is partly based on findings from a randomized trial of 118 patients on isotretinoin that sought to evaluate efficacy of omega-3 in reducing mucocutaneous side effects of isotretinoin
Studies and real-world use suggest that the injectable formulation can offer a more predictable and manageable side effect profile for most patients
